Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54


Silencing of Viral Elements: An Available Cure for Schizophrenia?

Klein HC.

Front Psychiatry. 2017 Dec 13;8:284. doi: 10.3389/fpsyt.2017.00284. eCollection 2017. No abstract available.


Determining the IgM and IgG antibodies titer against HSV1, HSV2 and CMV in the serum of schizophrenia patients.

Mohagheghi M, Eftekharian MM, Taheri M, Alikhani MY.

Hum Antibodies. 2018 Feb 5;26(2):87-93. doi: 10.3233/HAB-170325.


Emotion discrimination in humans: Its association with HSV-1 infection and its improvement with antiviral treatment.

Bhatia T, Wood J, Iyengar S, Narayanan SS, Beniwal RP, Prasad KM, Chen K, Yolken RH, Dickerson F, Gur RC, Gur RE, Deshpande SN, Nimgaonkar VL.

Schizophr Res. 2018 Mar;193:161-167. doi: 10.1016/j.schres.2017.08.001. Epub 2017 Aug 19.


Effects of Cumulative Herpesviridae and Toxoplasma gondii Infections on Cognitive Function in Healthy, Bipolar, and Schizophrenia Subjects.

Hamdani N, Daban-Huard C, Godin O, Laouamri H, Jamain S, Attiba D, Delavest M, Lépine JP, Le Corvoisier P, Houenou J, Richard JR, Yolken RH, Krishnamoorthy R, Tamouza R, Leboyer M, Dickerson FB.

J Clin Psychiatry. 2017 Jan;78(1):e18-e27. doi: 10.4088/JCP.15m10133.


Infection and inflammation in schizophrenia and bipolar disorder.

Tanaka T, Matsuda T, Hayes LN, Yang S, Rodriguez K, Severance EG, Yolken RH, Sawa A, Eaton WW.

Neurosci Res. 2017 Feb;115:59-63. doi: 10.1016/j.neures.2016.11.002. Epub 2016 Nov 14.


Seropositivity of neurotropic infectious agents in first-episode schizophrenia patients and the relationship with positive and negative symptoms.

Bolu A, Oznur T, Tok D, Balikci A, Sener K, Celik C, Gulsun M.

Psychiatr Danub. 2016 Jun;28(2):132-8.


The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls.

Dickerson F, Adamos MB, Katsafanas E, Khushalani S, Origoni A, Savage CLG, Schroeder J, Schweinfurth LAB, Stallings C, Sweeney K, Yolken R.

Schizophr Res. 2016 Oct;176(2-3):566-571. doi: 10.1016/j.schres.2016.05.022. Epub 2016 Jun 1.


Exposure to Perinatal Infections and Bipolar Disorder: A Systematic Review.

Barichello T, Badawy M, Pitcher MR, Saigal P, Generoso JS, Goularte JA, Simões LR, Quevedo J, Carvalho AF.

Curr Mol Med. 2016;16(2):106-18. Review.


The impact of Herpes simplex virus type 1 on cognitive impairments in young, healthy individuals - A historical prospective study.

Fruchter E, Goldberg S, Fenchel D, Grotto I, Ginat K, Weiser M.

Schizophr Res. 2015 Oct;168(1-2):292-6. doi: 10.1016/j.schres.2015.08.036. Epub 2015 Sep 8.


Influence of maternal infections on neonatal acute phase proteins and their interaction in the development of non-affective psychosis.

Blomström Å, Gardner RM, Dalman C, Yolken RH, Karlsson H.

Transl Psychiatry. 2015 Feb 3;5:e502. doi: 10.1038/tp.2014.142.


The association between antibodies to neurotropic pathogens and schizophrenia: a case-control study.

de Witte LD, van Mierlo HC, Litjens M, Klein HC, Bahn S, Osterhaus AD; GROUP Investigators.

NPJ Schizophr. 2015 Nov 4;1:15041. doi: 10.1038/npjschz.2015.41. eCollection 2015.


P-glycoprotein activity in the blood-brain barrier is affected by virus-induced neuroinflammation and antipsychotic treatment.

Doorduin J, de Vries EF, Dierckx RA, Klein HC.

Neuropharmacology. 2014 Oct;85:548-53. doi: 10.1016/j.neuropharm.2014.06.017. Epub 2014 Jun 25.


A longitudinal study of cognitive functioning in schizophrenia: clinical and biological predictors.

Dickerson F, Schroeder J, Stallings C, Origoni A, Katsafanas E, Schwienfurth LA, Savage CL, Khushalani S, Yolken R.

Schizophr Res. 2014 Jul;156(2-3):248-53. doi: 10.1016/j.schres.2014.04.019. Epub 2014 May 11.


Persistent infection by HSV-1 is associated with changes in functional architecture of iPSC-derived neurons and brain activation patterns underlying working memory performance.

D'Aiuto L, Prasad KM, Upton CH, Viggiano L, Milosevic J, Raimondi G, McClain L, Chowdari K, Tischfield J, Sheldon M, Moore JC, Yolken RH, Kinchington PR, Nimgaonkar VL.

Schizophr Bull. 2015 Jan;41(1):123-32. doi: 10.1093/schbul/sbu032. Epub 2014 Mar 12.


Mortality in schizophrenia: clinical and serological predictors.

Dickerson F, Stallings C, Origoni A, Schroeder J, Khushalani S, Yolken R.

Schizophr Bull. 2014 Jul;40(4):796-803. doi: 10.1093/schbul/sbt113. Epub 2013 Aug 13.


Exposure to herpes simplex virus, type 1 and reduced cognitive function.

Thomas P, Bhatia T, Gauba D, Wood J, Long C, Prasad K, Dickerson FB, Gur RE, Gur RC, Yolken RH, Nimgaonkar VL, Deshpande SN.

J Psychiatr Res. 2013 Nov;47(11):1680-5. doi: 10.1016/j.jpsychires.2013.07.010. Epub 2013 Aug 3.


Susceptibility genes are enriched in those of the herpes simplex virus 1/host interactome in psychiatric and neurological disorders.

Carter CJ.

Pathog Dis. 2013 Dec;69(3):240-61. doi: 10.1111/2049-632X.12077. Epub 2013 Sep 2.


Neurotropic infectious agents and cognitive impairment in schizophrenia.

Nimgaonkar VL, Yolken RH.

Schizophr Bull. 2012 Nov;38(6):1135-6. doi: 10.1093/schbul/sbs125. Epub 2012 Oct 31.


Persistent infection with neurotropic herpes viruses and cognitive impairment.

Watson AM, Prasad KM, Klei L, Wood JA, Yolken RH, Gur RC, Bradford LD, Calkins ME, Richard J, Edwards N, Savage RM, Allen TB, Kwentus J, McEvoy JP, Santos AB, Wiener HW, Go RC, Perry RT, Nasrallah HA, Gur RE, Devlin B, Nimgaonkar VL.

Psychol Med. 2013 May;43(5):1023-31. doi: 10.1017/S003329171200195X. Epub 2012 Sep 14.


Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure.

Bamne M, Wood J, Chowdari K, Watson AM, Celik C, Mansour H, Klei L, Gur RC, Bradford LD, Calkins ME, Santos AB, Edwards N, Kwentus J, McEvoy JP, Allen TB, Savage RM, Nasrallah HA, Gur RE, Perry RT, Go RC, Devlin B, Yolken R, Nimgaonkar VL.

Schizophr Bull. 2012 Nov;38(6):1149-54. doi: 10.1093/schbul/sbs087. Epub 2012 Sep 10.

Supplemental Content

Loading ...
Support Center